Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2018-04-25 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
关于中信资本控股有限公司收到《商务部经营者集中反垄断审查不予禁止审查决定书》的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the receipt of a decision from the Ministry of Commerce about an anti-monopoly review related to a capital increase and change in control of the company. It details the transaction parties, shareholding changes, and regulatory approvals needed. The document is short (1105 characters) and serves as a public notice of a regulatory decision and transaction update rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. Therefore, it fits best as a Capital/Financing Update (CAP) since it concerns a capital increase and change in ownership structure.
2018-04-25 Chinese
2017年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an 'Implementation Announcement of the 2017 Annual Equity Distribution' by 哈药集团股份有限公司 (Harbin Pharmaceutical Group Co., Ltd.). It details the dividend distribution plan for the 2017 fiscal year, including dividend per share, relevant dates (record date, ex-dividend date, payment date), tax treatment, and instructions for shareholders. The document is an announcement of the dividend amount and payment details rather than the dividend report itself. The length is 2248 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of 'Notice of Dividend Amount' (DIV).
2018-04-24 Chinese
2018年第一季度报告
Interim / Quarterly Report Classification · 98% confidence The document is titled "2018 年第一季度报告" which translates to "2018 First Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2018. The document includes unaudited financial statements, management explanations of financial changes, shareholder information, and other comprehensive financial disclosures typical of a quarterly financial report. The length is about 15,000 characters, indicating a full report rather than a brief announcement. There is no indication that this is an annual report, audit report, or earnings release summary. The presence of detailed financial statements and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report (IR). Q1 2018
2018-04-15 Chinese
八届三次监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (616 characters) from the supervisory board of 哈药集团股份有限公司 regarding their review and approval of the 2018 first quarter report. It states that the supervisory board has audited the 2018 Q1 report and confirms its compliance and accuracy. However, the document itself does not contain the actual financial statements or substantive financial data of the quarterly report; it is a formal announcement of the supervisory board's resolution and opinion on the report. According to the 'Menu vs Meal' rule, such a short document that announces or certifies a report without including the report itself should be classified as a Regulatory Filing (RNS).
2018-04-15 Chinese
八届六次董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a board resolution announcement from Harbin Pharmaceutical Group Co., Ltd. regarding the approval of the 2018 first quarter report. It states that the board meeting was held and the quarterly report was approved unanimously. The document is short (439 characters) and refers readers to the full quarterly report published on the Shanghai Stock Exchange website. It does not contain the actual financial statements or substantive financial data itself, but rather announces the board's approval and points to the full report elsewhere. According to the 'Menu vs Meal' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement about the board meeting and report approval without the full report content included.
2018-04-15 Chinese
关于完成工商变更登记手续的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement regarding the completion of a change in the company's registered capital and related business registration procedures. It mentions the completion of the repurchase and cancellation of restricted shares, the change in registered capital, and the approval of these changes by the board and shareholders. The document is short (495 characters) and serves as an official notice of a capital change rather than a detailed financial report or a full report. Therefore, it fits the category of Share Issue/Capital Change announcements.
2018-03-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.